Intervenciones en infecciones del tracto urinario, neumonías, COVID-19 y bacteriemias por programas de uso optimizado de antimicrobianos (PROA): enfoque síndrome específico: La información cruda anonimizada no podrá ser compartida. . Los autores declaran que no hubo financiamiento para la realización de este trabajo. .La información cruda anonimizada no podrá ser compartida.

Objective: to describe the benefit of syndrome-specific interventions in urinary tract infections, pneumonia, bacteremia and COVID-19, performed by optimized antimicrobial use programs (PROA). Methodology: we searched PubMed and selected those articles in which interventions showing clinical benefits in urinary tract infections, pneumonia, COVID-19 and bacteremia were performed by optimized antimicrobial use programs (PROA). Data synthesis: 18 studies were selected. 3 of these studies showed beneficial interventions in the treatment of urinary tract infections, 9 in pneumonia, 1 in COVID-19 and 5 in bacteremia. Conclusion: syndrome-specific interventions in urinary tract infections, pneumonia, COVID-19 and bacteremia through optimized antimicrobial use programs have been associated with lower costs of care and better clinical outcomes.